Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomised Controlled Trial of Continuous Beta-lactam Infusion Compared With Intermittent Beta-lactam Dosing in Critically Ill Patients

NCT03213990 is registered in ClinicalTrials.gov with The George Institute as lead sponsor.

NCT NCT03213990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03213990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomised Controlled Trial of Continuous Beta-lactam Infusion Compared With Intermittent Beta-lactam Dosing in Critically Ill Patients
Lead sponsor
The George Institute
Phase
Not applicable
Overall status
Completed
Start date
March 26, 2018
Completion date
June 29, 2023
Enrollment
7,203 (actual)
Sites
103

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis